Post Title
LOREM IPSUM DOLOR SIT AMET

The Spanish regulatory agency has approved the APRIL clinical trial, a Phase 1b/2a study to assess the safety and efficacy of ApTOLL in acute ischemic stroke patients.

Leave a comment